ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
Dow Jones
37.815,92
-1,49%
Euro vs US Dollar
1,06697
0,03%
Bitcoin
57.204,85
-5,60%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rigel Pharmaceuticals Inc (RIGL)

  7. Rigel Pharmaceuticals Inc (RIGL) News

RIGL Rigel Pharmaceuticals Inc

1,05
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:43:11
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Rigel Pharmaceuticals Inc RIGL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 1,05 10:43:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,05
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202414:05PRNUSRigel Announces Conference Call and Webcast to Report First..
10.4.202422:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04.4.202414:05PRNUSRigel Announces Publication of Data on REZLIDHIA®..
12.3.202413:05PRNUSRigel Pharmaceuticals Announces Appointment of Lisa..
05.3.202422:10EDGAR2Form 8-K - Current report
05.3.202422:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05.3.202422:01PRNUSRigel Reports Fourth Quarter and Full Year 2023 Financial..
02.3.202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202414:05PRNUSRigel Announces Conference Call and Webcast to Report Fourth..
22.2.202414:00EDGAR2Form 8-K - Current report
22.2.202413:50PRNUSRigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
14.2.202420:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202415:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26.1.202403:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202403:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202403:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.1.202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.1.202414:30EDGAR2Form 8-K - Current report
08.1.202414:05PRNUSRigel Pharmaceuticals Provides Business Update
05.1.202422:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
04.1.202414:05PRNUSRigel Announces Collaboration with CONNECT to Conduct a..
03.1.202414:05PRNUSRigel to Present at the 42nd Annual J.P. Morgan Healthcare..
08.12.202314:05PRNUSRigel Pharmaceuticals and MD Anderson Announce Strategic..
30.11.202312:04EDGAR2Form 8-K - Current report
07.11.202322:16EDGAR2Form 8-K - Current report
07.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202322:01PRNUSRigel Reports Third Quarter 2023 Financial Results and..
06.11.202314:05PRNUSRigel to Present at the Jefferies London Healthcare..
02.11.202314:27PRNUSRigel Announces Poster Presentations at the 65th American..
31.10.202313:05PRNUSRigel Announces Conference Call and Webcast to Report Third..
11.10.202314:05PRNUSRigel Announces Presentation at the Upcoming IDWeek 2023
06.10.202322:30PRNUSRigel Announces Inducement Grants under NASDAQ Listing Rule..
20.9.202314:05PRNUSRigel to Present at the 2023 Cantor Global Healthcare..
30.8.202314:05PRNUSRigel to Participate in Upcoming September Investor..
01.8.202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
01.8.202322:15EDGAR2Form 8-K - Current report
01.8.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202322:01PRNUSRigel Reports Second Quarter 2023 Financial Results and..
25.7.202314:00PRNUSRigel Announces Conference Call and Webcast to Report Second..
13.7.202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.7.202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.7.202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.7.202300:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
RIGL
Rigel Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten